Rapid rituximab infusion is safe in paediatric and young adult patients with non-malignant indications

Br J Haematol. 2016 May;173(3):480-1. doi: 10.1111/bjh.13604. Epub 2015 Jul 24.
No abstract available

Keywords: anti-CD20 antibody; haematopoietic cell transplant; rapid rituximab infusion; rituximab.

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Agents, Immunological / administration & dosage*
  • Antineoplastic Agents, Immunological / adverse effects
  • Autoimmune Diseases / drug therapy
  • Child
  • Child, Preschool
  • Drug Evaluation
  • Graft vs Host Disease / drug therapy
  • Humans
  • Infant
  • Retrospective Studies
  • Rituximab / administration & dosage*
  • Rituximab / adverse effects
  • Time Factors
  • Treatment Outcome
  • Tumor Lysis Syndrome / etiology
  • Viremia / drug therapy
  • Young Adult

Substances

  • Antineoplastic Agents, Immunological
  • Rituximab